Abstract

The prevalence of head and neck cancers continues to increase throughout the world, the modality of their management mainly includes surgery, radiotherapy (RTH), and chemotherapy and antiresorptive treatment.The complications of radiotherapy imperatively require concerted management and rigorous monitoring. Indeed, collaboration with the multidisciplinary team is essential and guarantees therapeutic success.The management of patients during and after these anticancer treatments by the specialist in maxillofacial prosthesis essentially comprises the treatment of early and late complications of radiotherapy, oral care and finally prosthetic rehabilitation depending on the case.The objective of this work is to describe the protocols and recommendations for the management of patients during and after radiotherapy and to highlight the role of the specialist in maxillofacial prosthodontics in this management.

Highlights

  • Comme nous l’avons vu au niveau de la première partie, la prise en charge (PEC) du patient cancéreux par le spécialiste en prosthodontie maxillo-faciale débute avant la radiothérapie (RTH)

  • The prevalence of head and neck cancers continues to increase throughout the world

  • de nombreux patients ne sont reçus qu'en cours ou après la radiothérapie

Read more

Summary

Mediterranean Journals Integrative Journal of Medical Sciences

Radiotherapy and Management in Maxillofacial Prosthodontic: Part 2 - During and After Radiotherapy.

INTRODUCTION
CONCLUSION
The Role of Botulinum Toxin Type A in the Radiation
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call